Causes,consequences and public health implications of low B-vitamin status in ageing

Nutrients

Volumn 8, Issue 11, 2016, Pages

  Porter, Kirsty ^a   Hoey, Leane ^a   Hughes, Catherine F ^a   Ward, Mary ^a   McNulty, Helene ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Ageing; B vitamins; Cardiovascular disease; Cognitive dysfunction; Degenerative diseases; Dementia; Methylenetetrahydrofolate reductase (MTHFR); Osteoporosis

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLUTATHIONE REDUCTASE; HISTAMINE H2 RECEPTOR ANTAGONIST; HOMOCYSTEINE; MYELIN; NEUROTRANSMITTER; PHOSPHOLIPID; PROTON PUMP INHIBITOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE PHOSPHATE OXIDASE; RIBOFLAVIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; SUCCINYL COENZYME A; VITAMIN B GROUP; VITAMIN B COMPLEX;

AGING; BONE DENSITY; CARBON METABOLISM; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; DNA SYNTHESIS; ENZYME ACTIVITY; ERYTHROCYTE; GENETIC POLYMORPHISM; HUMAN; MALABSORPTION; META ANALYSIS (TOPIC); NUTRITIONAL STATUS; OSTEOPOROSIS; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RNA SYNTHESIS; SYSTEMATIC REVIEW (TOPIC); VITAMIN DEFICIENCY; DIET; DIETARY SUPPLEMENT;

AGING; DIET; DIETARY SUPPLEMENTS; HUMANS; NUTRITIONAL STATUS; VITAMIN B COMPLEX; VITAMIN B DEFICIENCY;

EID: 84996538935     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8110725     Document Type: Review

References (249)

1. Beard,J.R.; Bloom,D.E. Towards a comprehensive public health response to population ageing. Lancet 2015,385,658-661. [CrossRef]
2. Prince,M.;Wu,F.; Guo,Y.; Gutierrez Robledo,L.; O’Donnell,M.; Sullivan,R.; Yusuf,S. The burden of disease in older people and implications for health policy and practice. Lancet 2015,385,549-562. [CrossRef]
3. A Global Brief on Hypertension. Available online: http://ish-world.com/news/a/World-Health-Organization-A-Global-Brief-on-Hypertension/ (accessed on 1 August 2016).
4. Johnell,O.; Kanis,J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos. Int. 2006,17,1726-1733. [CrossRef] [PubMed]
5. Prince,M.; Wimo,A.; Guerchet,M.; Ali,G.C.; Wu,Y.-T.; Prina,M.; International,A.D. World Alzheimer’s Report-The Global Impact of Dementia; Alzheimer’s Disease International: London,UK,2015.
6. Selhub,J. Folate,vitamin B12 and vitamin B6 and one carbon metabolism. J. Nutr. Health Aging 2002,6,39-42. [PubMed]
7. Kennedy,D.O. B Vitamins and the Brain: Mechanisms,Dose and Efficacy-A Review. Nutrients 2016,8,68. [CrossRef] [PubMed]
8. McGarel,C.; Pentieva,K.; Strain,J.J.; McNulty,H. Emerging roles for folate and related B-vitamins in brain health across the lifecycle. Proc. Nutr. Soc. 2015,74,46-55. [CrossRef] [PubMed]
9. Molloy,A. Folate-vitamin B12 interrelationships; links to disease risk. In Folate in Health and Disease,2nd ed.; Bailey,L.,Ed.; CRC Press: Boca Raton,FL,USA,2010; pp. 381-408.
10. Scott,J.;Weir,D. The methyl folate trap: A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid-induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet 1981,318,337-340. [CrossRef]
11. Brachet,P.; Chanson,A.; Demigne,C.; Batifoulier,F.; Alexandre-Gouabau,M.C.; Tyssandier,V.; Rock,E. Age-associated B vitamin deficiency as a determinant of chronic diseases. Nutr. Res. Rev. 2004,17,55-68. [CrossRef] [PubMed]
12. Araujo,J.R.; Martel,F.; Borges,N.; Araujo,J.M.; Keating,E. Folates and aging: Role in mild cognitive impairment,dementia and depression. Ageing Res. Rev. 2015,22,9-19. [CrossRef] [PubMed]
13. Lai,C.; Parnell,L.D.; Troen,A.M.; Shen,J.; Caouette,H.;Warodomwichit,D.; Lee,Y.; Crott,J.W.; Qiu,W.Q.; Rosenberg,I.H.; et al. MAT1A variants are associated with hypertension,stroke,and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am. J. Clin. Nutr. 2010,91,1377-1386. [CrossRef] [PubMed]
14. Wilcken,B.; Bamforth,F.; Li,Z.; Zhu,H.; Ritvanen,A.; Redlund,M.; Stoll,C.; Alembik,Y.; Dott,B.; Czeizel,A.E.; et al. Geographical and ethnic variation of the 677C > T allele of 5,10-methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areasWorldwide. J. Med. Genet. 2003,40,619-625. [CrossRef] [PubMed]
15. Reilly,R.; Hopkins,S.;Ward,M.; McNulty,H.; McCann,A.; McNulty,B.;Walton,J.; Molloy,A.; Strain,J.J.; Flynn,A.; et al. MTHFR 677TT genotype and related B-vitamins: Novel determinants of hypertension in healthy Irish adults. J. Inherit. Metab. Dis. 2013,36,35.
16. Clarke,M.; Ward,M.; Dickey,W.; Hoey,L.; Molloy,A.M.; Waldron,L.; Varghese,A.; McCann,A.; Blayney,J.K.; McNulty,H. B-vitamin status in relation to bone mineral density in treated celiac disease patients. Scand. J. Gastroenterol. 2015,50,975-984. [CrossRef] [PubMed]
17. Ter Borg,S.; Verlaan,S.; Hemsworth,J.; Mijnarends,D.M.; Schols,J.M.G.A.; Luiking,Y.C.; De Groot,L.C.P.G.M. Micronutrient intakes and potential inadequacies of community-dwelling older adults: A systematic review. Br. J. Nutr. 2015,113,1195-1206. [CrossRef] [PubMed]
18. Bates,B.; Lennox,A.; Bates,C. National Diet and Nutrition Survey: Results from Years 1-4 (Combined) of the Rolling Programme (2008/2009-2011/12); Public Health England: London,UK,2014.
19. Lindenbaum,J.; Allen,R. Clinical spectrum and diagnosis of folate deficiency. In Folate in Health and Disease,2nd ed.; Bailey,L.,Ed.; CRC Press: London,UK,2009; pp. 43-67.
20. Bailey,L.B.; Stover,P.J.; McNulty,H.; Fenech,M.F.; Gregory,J.F.,III; Mills,J.L.; Pfeiffer,C.M.; Fazili,Z.; Zhang,M.; Ueland,P.M.; et al. Biomarkers of Nutrition for Development-Folate Review. J. Nutr. 2015,145,1636-1680. [CrossRef] [PubMed]
21. Gibson,R. Assessment status of riboflavin,B6,folate and B12 status. In Principles of Nutritional Assessment,2nd ed.; Oxford University: New York,NY,USA,2005; pp. 554-562,575-640.
22. Carmel,R.; Jacobsen,D. (Eds.) Homocysteine in Health and Disease; Cambridge University Press: Cambridge,UK,2001.
23. Selhub,J.; Jacques,P.F.; Bostom,A.G.; Wilson,P.W.; Rosenberg,I.H. Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev. 2000,28,117-145. [PubMed]
24. McKillop,D.; Pentieva,K.; Daly,D.; McPartlin,J.; Hughes,J.; Strain,J.; Scott,J.; McNulty,H. The effect of different cooking methods on folate retention in various foods that are amongst the major contributors to folate intake in the UK diet. Br. J. Nutr. 2002,88,681-688. [CrossRef] [PubMed]
25. McNulty,H.; Scott,J.M. Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status. Br. J. Nutr. 2008,99,S48-S54. [CrossRef] [PubMed]
26. Selhub,J.; Bagley,L.C.; Miller,J.; Rosenberg,I.H. B vitamins,homocysteine,and neurocognitive function in the elderly. Am. J. Clin. Nutr. 2000,71,614S-620S. [PubMed]
27. Powers,H.J. Riboflavin (vitamin B-2) and health. Am. J. Clin. Nutr. 2003,77,1352-1360. [PubMed]
28. Allen,L.H. How common is vitamin B-12 deficiency? Am. J. Clin. Nutr. 2009,89,693S-696S. [CrossRef] [PubMed]
29. Refsum,H.; Yajnik,C.S.; Gadkari,M.; Schneede,J.; Vollset,S.E.; Orning,L.; Guttormsen,A.B.; Joglekar,A.; Sayyad,M.G.; Ulvik,A.; et al. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am. J. Clin. Nutr. 2001,74,233-241. [PubMed]
30. Antony,A.C. Prevalence of cobalamin (vitamin B-12) and folate deficiency in India-Audi alteram partem. Am. J. Clin. Nutr. 2001,74,233-241.
31. Clarke,R.; Refsum,H.; Birks,J.; Evans,J.G.; Johnston,C.; Sherliker,P.; Ueland,P.M.; Schneede,J.; McPartlin,J.; Nexo,E.; et al. Screening for vitamin B-12 and folate deficiency in older persons. Am. J. Clin. Nutr. 2003,77,1241-1247. [PubMed]
32. Clarke,R.; Sherliker,P.; Hin,H.; Nexo,E.; Hvas,A.M.; Schneede,J.; Birks,J.; Ueland,P.M.; Emmens,K.; Scott,J.M.; et al. Detection of vitamin B-12 deficiency in older people by measuring vitamin B-12 or the active fraction of vitamin B-12,holotranscobalamin. Clin. Chem. 2007,53,963-970. [CrossRef] [PubMed]
33. Clarke,R.; Grimley Evans,J.; Schneede,J.; Nexo,E.; Bates,C.; Fletcher,A.; Prentice,A.; Johnston,C.; Ueland,P.M.; Refsum,H.; et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004,33,34-41. [CrossRef] [PubMed]
34. Pfeiffer,C.M.; Caudill,S.P.; Gunter,E.W.; Osterloh,J.; Sampson,E.J. Biochemical indicators of B vitamin status in the US population after folic acid fortification: Results from the National Health and Nutrition Examination Survey 1999-2000. Am. J. Clin. Nutr. 2005,82,442-450. [PubMed]
35. Pfeiffer,C.M.; Johnson,C.L.; Jain,R.B.; Yetley,E.A.; Picciano,M.F.; Rader,J.I.; Fisher,K.D.; Mulinare,J.; Osterloh,J.D. Trends in blood folate and vitamin B-12 concentrations in the United States,1988-2004. Am. J. Clin. Nutr. 2007,86,718-727. [PubMed]
36. MacFarlane,A.J.; Greene-Finestone,L.S.; Shi,Y. Vitamin B-12 and homocysteine status in a folate-replete population: Results from the Canadian Health Measures Survey. Am. J. Clin. Nutr. 2011,94,1079-1087. [CrossRef] [PubMed]
37. Green,T.J.; Venn,B.J.; Skeaff,C.M.; Williams,S.M. Serum vitamin B-12 concentrations and atrophic gastritis in older New Zealanders. Eur. J. Clin. Nutr. 2005,59,205-210. [CrossRef] [PubMed]
38. Loikas,S.; Koskinen,P.; Irjala,K.; Lopponen,M.; Isoaho,R.; Kivela,S.; Pelliniemi,T. Vitamin B12 deficiency in the aged: A population-based study. Age Ageing 2007,36,177-183. [CrossRef] [PubMed]
39. Carmel,R. Cobalamin,the stomach,and aging. Am. J. Clin. Nutr. 1997,66,750-759. [PubMed]
40. Hughes,C.F.; Ward,M.; Hoey,L.; McNulty,H. Vitamin B-12 and ageing: Current issues and interaction with folate. Ann. Clin. Biochem. 2013,50,315-329. [CrossRef] [PubMed]
41. Van Asselt,D.Z.B.; De Groot,L.C.P.G.M.; Van Staveren,W.A.; Blom,H.J.; Wevers,R.A.; Biemond,I.; Hoefnagels,W.H.L. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am. J. Clin. Nutr. 1998,68,328-334. [PubMed]
42. Hannibal,L.; Lysne,V.; Bjørke-Monsen,A.L.; Behringer,S.; Grünert,S.C.; Spiekerkoetter,U.; Jacobsen,D.W.; Blom,H.J. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency. Front. Mol. Biosci. 2016,3,27. [CrossRef] [PubMed]
43. Valuck,R.J.; Ruscin,J.M. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B-12 deficiency in older adults. J. Clin. Epidemiol. 2004,57,422-428. [CrossRef] [PubMed]
44. Masclee,G.M.C.; Sturkenboom,M.C.J.M.; Kuipers,E.J. A Benefit-Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly. Drugs Aging 2014,31,263-282. [CrossRef] [PubMed]
45. Lam,J.R.; Schneider,J.L.; Zhao,W.; Corley,D.A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B-12 deficiency. JAMA 2013,310,2435-2442. [CrossRef] [PubMed]
46. Chapman,L.E.; Darling,A.L.; Brown,J.E. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab. 2016. [CrossRef] [PubMed]
47. Aroda,V.R.; Edelstein,S.L.; Goldberg,R.B.; Knowler,W.C.; Marcovina,S.M.; Orchard,T.J.; Bray,G.A.; Schade,D.S.; Temprosa,M.G.; White,N.H.; et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J. Clin. Endocrinol. Metab. 2016,101,1754-1761. [CrossRef] [PubMed]
48. Haller,J. The vitamin status and its adequacy in the elderly: An international overview. Int. J. Vitam. Nutr. Res. 1999,69,160-168. [CrossRef] [PubMed]
49. Bates,C.; Pentieva,K.; Prentice,A.; Mansoor,M.; Finch,S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br. J. Nutr. 1999,81,191-201. [PubMed]
50. Morris,M.S.; Picciano,M.F.; Jacques,P.F.; Selhub,J. Plasma pyridoxal 50-phosphate in the US population: The National Health and Nutrition Examination Survey,2003-2004. Am. J. Clin. Nutr. 2008,87,1446-1454. [PubMed]
51. Ribayamercado,J.; Russell,R.; Sahyoun,N.; Morrow,F.; Gershoff,S. Vitamin-B6 requirements of elderly men and women. J. Nutr. 1991,121,1062-1074.
52. Van Den Berg,H. Vitamin B6 status and requirements in older adults. Br. J. Nutr. 1999,81,175-176. [PubMed]
53. Troesch,B.; Hoeft,B.; McBurney,M.; Eggersdorfer,M.;Weber,P. Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br. J. Nutr. 2012,108,692-698. [CrossRef] [PubMed]
54. Bates,B.; Cox,L.; Page,S.; Prentice,A.; Steer,T.; Swan,G. National Diet and Nutrition Survey: Results from Years 5 and 6 (Combined) of the Rolling Programme (2012/2013-2013/2014); Public Health England: London,UK,2016.
55. Walton,J.; Flynn,A. NANS: Food and Nutrient Intakes,Physical Measurements,Physical Activity Patterns and Food Choice Motives; Irish Universities Nutrition Alliance: Dublin,Ireland,2011; pp. 1-40.
56. Eussen,S.J.P.M.; De Groot,C.P.G.M.; Clarke,R.; Schneede,J.; Ueland,P.M.; Hoefnagels,W.H.L.; Van Staveren,W.A. Oral cyanocobalamin supplementation in older people with vitamin B-12 deficiency-A dose-finding trial. Arch. Intern. Med. 2005,165,1167-1172. [CrossRef] [PubMed]
57. McKinley,M.C.; McNulty,H.; McPartlin,J.; Strain,J.J.; Pentieva,K.; Ward,M.; Weir,D.G.; Scott,J.M. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am. J. Clin. Nutr. 2001,73,759-764. [PubMed]
58. McNulty,H.; Dowey,L.R.C.; Strain,J.J.; Dunne,A.; Ward,M.; Molloy,A.M.; McAnena,L.B.; Hughes,J.P.; Hannon-Fletcher,M.; Scott,J.M. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C ! T polymorphism. Circulation 2006,113,74-80. [CrossRef] [PubMed]
59. Pfeiffer,C.; Fazili,Z.; Zhang,M. Folate analytical methodology. In Folate in Health and Disease,2nd ed.; Bailey,L.B.,Ed.; CRC Press: Boca Raton,FL,USA,2010; pp. 517-574.
60. Mason,J.B. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J. Nutr. 2003,133,941S-947S. [PubMed]
61. Clifford,A.J.; Noceti,E.M.; Block-Joy,A.; Block,T.; Block,G. Erythrocyte folate and its response to folic acid supplementation is assay dependent in women. J. Nutr. 2005,135,137-143. [PubMed]
62. Wu,A.; Chanarin,I.; Slavin,G.; Levi,A.J. Folate-Deficiency in alcoholic-Relationship to clinical and hematological abnormalities,liver-disease and folate stores. Br. J. Haematol. 1975,29,469-478. [CrossRef] [PubMed]
63. Duffy,M.E.; Hoey,L.; Hughes,C.F.; Strain,J.J.; Rankin,A.; Souverein,O.W.; Dullemeijer,C.; Collings,R.; Hooper,L.; McNulty,H. Biomarker responses to folic acid intervention in healthy adults: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014,99,96-106. [CrossRef] [PubMed]
64. Carmel,R. Current concepts in cobalamin deficiency. Annu. Rev. Med. 2000,51,357-375. [CrossRef] [PubMed]
65. Lindenbaum,J.; Rosenberg,I.H.; Wilson,P.W.F.; Stabler,S.P.; Allen,R.H. Prevalence of cobalamin deficiency in the Framingham elderly population. Am. J. Clin. Nutr. 1994,60,2-11. [PubMed]
66. Naurath,H.J.; Joosten,E.; Riezler,R.; Stabler,S.P.; Allen,R.H.; Lindenbaum,J. Effects of vitamin-B12,folate,and vitamin-B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 1995,346,85-89. [CrossRef]
67. Carmel,R.; Green,R.; Jacobsen,D.W.; Rasmussen,K.; Florea,M.; Azen,C. Serum cobalamin,homocysteine,and methylmalonic acid concentrations in a multiethnic elderly population: Ethnic and sex differences in cobalamin and metabolite abnormalities. Am. J. Clin. Nutr. 1999,70,904-910. [PubMed]
68. Riedel,B.M.; Molloy,A.M.; Meyer,K.; Fredriksen,A.; Ulvik,A.; Schneede,J.; Nexo,E.; Hoff,G.; Ueland,P.M. Transcobalamin Polymorphism 67A ! G,but Not 776C ! G,Affects serum holotranscobalamin in a cohort of healthy middle-aged men and women. J. Nutr. 2011,141,1784-1790. [CrossRef] [PubMed]
69. Iqbal,N.; Azar,D.; Yun,Y.; Ghausi,O.; Ix,J.; Fitzgerald,R.L. Serum methylmalonic Acid and holotranscobalamin-II as markers for vitamin b12 deficiency in end-stage renal disease patients. Ann. Clin. Lab. Sci. 2013,43,243-249. [PubMed]
70. Carmel,R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: A critical overview of context,applications,and performance characteristics of cobalamin,methylmalonic acid,and holotranscobalamin II. Am. J. Clin. Nutr. 2011,94,348S-358S. [CrossRef] [PubMed]
71. Leklem,J.E. Vitamin-B6-A status-report. J. Nutr. 1990,120,1503-1507. [PubMed]
72. Ueland,P.M.; Ulvik,A.; Rios-Avila,L.; Midttun,O.; Gregory,J.F. Direct and functional biomarkers of vitamin b6 status. Annu. Rev. Nutr. 2015,35,33-70. [CrossRef] [PubMed]
73. Chiang,E.P.; Smith,D.E.; Selhub,J.; Dallal,G.; Wang,Y.C.; Roubenoff,R. Inflammation causes tissue-specific depletion of vitamin B-6. Arthritis Res. Ther. 2005,7,R1254-R1262. [CrossRef] [PubMed]
74. Hoey,L.; McNulty,H.; Strain,J.J. Studies of biomarker responses to intervention with riboflavin: A systematic review. Am. J. Clin. Nutr. 2009,89,1960S-1980S. [CrossRef] [PubMed]
75. Yetley,E.A.; Johnson,C.L. Folate and vitamin B-12 biomarkers in NHANES: History of their measurement and use. Am. J. Clin. Nutr. 2011,94,322S-331S. [CrossRef] [PubMed]
76. Hoey,L.; Strain,J.J.; McNulty,H. Studies of biomarker responses to intervention with vitamin B-12: A systematic review of randomized controlled trials. Am. J. Clin. Nutr. 2009,89,1981S-1996S. [CrossRef] [PubMed]
77. Bisp,M.R.; Bor,M.V.; Heinsvig,E.M.; Kall,M.A.; Nexo,E. Determination of vitamin B6 vitamers and pyridoxic acid in plasma: Development and evaluation of a high-performance liquid chromatographic assay. Anal. Biochem. 2002,305,82-89. [CrossRef] [PubMed]
78. Apeland,T.; Mansoor,M.A.; Pentieva,K.; McNulty,H.; Strandjord,R.E. Fasting and post-methionine loading concentrations of homocysteine,vitamin B2,and vitamin B6 in patients on antiepileptic drugs. Clin. Chem. 2003,49,1005-1008. [CrossRef] [PubMed]
79. Reynolds,E. Vitamin B12,folic acid,and the nervous system. Lancet Neurol. 2006,5,949-960. [CrossRef]
80. Scott,J.;Weir,D. Folate/vitamin B12 inter-relationships. Essays Biochem. 1994,28,63-72. [PubMed]
81. Healton,E.; Brust,J.; Garrett,T.; Lindenbaum,J. Neurologic aspects of coabalmin deficiency. Medicine 1991,70,229-245. [CrossRef] [PubMed]
82. Rampersaud,G.C.; Kauwell,G.P.A.; Bailey,L.B. Folate: A key to optimizing health and reducing disease risk in the elderly. J. Am. Coll. Nutr. 2003,22,1-8. [CrossRef] [PubMed]
83. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002,288,2015-2022.
84. Wald,D.S.; Law,M.; Morris,J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. Br. Med. J. 2002,325,1202K-1206K. [CrossRef]
85. Smith,D.A.; Refsum,H. Homocysteine,B Vitamins,and Cognitive Impairment. Annu. Rev. Nutr. 2016,36,211-239. [CrossRef] [PubMed]
86. Wald,D.S.; Morris,J.K.; Wald,N.J. Reconciling the Evidence on Serum Homocysteine and Ischaemic Heart Disease: A Meta-Analysis. PLoS ONE 2011,6,e16473. [CrossRef] [PubMed]
87. Wald,D.S.; Kasturiratne,A.; Simmonds,M. Serum homocysteine and dementia: Meta-analysis of eight cohort studies including 8669 participants. Alzheimer’s Dement. 2011,7,412-417. [CrossRef] [PubMed]
88. Yang,H.; Lee,M.; Hong,K.; Ovbiagele,B.; Saver,J.L. Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Eur. J. Intern. Med. 2012,23,745-754. [CrossRef] [PubMed]
89. Enneman,A.W.; Swart,K.M.; VanWijngaarden,J.P.; Zillikens,M.C.; Dhonukshe-Rutten,R.A.; De Groot,L.C.; Van Schoor,N.M.; Lips,P.; Van Meurs,J.B.; Uitterlinden,A.G.; et al. Association between plasma homocysteine and bone density and quality parameters in the elderly. Bone 2012,50,S134. [CrossRef]
90. McNulty,H.; Strain,J.J.; Pentieva,K.; Ward,M. C-1 metabolism and CVD outcomes in older adults. Proc. Nutr. Soc. 2012,71,213-221. [CrossRef] [PubMed]
91. Toole,J.F.; Malinow,M.R.; Chambless,L.E.; Spence,J.D.; Pettigrew,L.C.; Howard,V.J.; Sides,E.G.; Wang,C.; Stampfer,M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke,myocardial infarction,and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004,291,565-575. [CrossRef] [PubMed]
92. Bonaa,K.H.; Njolstad,I.; Ueland,P.M.; Schirmer,H.; Tverdal,A.; Steigen,T.; Wang,H.; Nordrehaug,J.E.; Arnesen,E.; Rasmussen,K. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006,354,1578-1588. [CrossRef] [PubMed]
93. Lonn,E.; Yusuf,S.; Arnold,M.J.; Sheridan,P.; Pogue,J.; Micks,M.; McQueen,M.J.; Probstfield,J.; Fodor,G.; Held,C.; et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006,354,1567-1577. [PubMed]
94. Albert,C.M.; Cook,N.R.; Gaziano,J.M.; Zaharris,E.; MacFadyen,J.; Danielson,E.; Buring,J.E.; Manson,J.E. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 2008,299,2027-2036. [CrossRef] [PubMed]
95. Ebbing,M.; Bleie,O.; Ueland,P.M.; Nordrehaug,J.E.; Nilsen,D.W.; Vollset,S.E.; Refsum,H.; Pedersen,E.K.R.; Nygard,O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography-A Randomized controlled trial. JAMA 2008,300,795-804. [CrossRef] [PubMed]
96. Hankey,G.J.; Eikelboom,J.W.; Baker,R.I.; Gelavis,A.; Hickling,S.C.; Jamrozik,K.; Van Bockxmeer,F.M.; Vasikaran,S.; Hankey,G.J.; Chen,C.; et al. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised,double-blind,parallel,placebo-controlled trial. Lancet Neurol. 2010,9,855-865.
97. Clarke,R.; Bennett,D.A.; Parish,S.; Verhoef,P.; Dotsch-Klerk,M.; Lathrop,M.; Xu,P.; Nordestgaard,B.G.; Holm,H.; Hopewell,J.C.; et al. Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies,Avoiding Publication Bias. PLoS Med. 2012,9,e1001177. [CrossRef] [PubMed]
98. Yang,Q.H.; Botto,L.D.; Erickson,J.D.; Berry,R.J.; Sambell,C.; Johansen,H.; Friedman,J.M. Improvement in stroke mortality in Canada and the United States,1990 to 2002. Circulation 2006,113,1335-1343. [CrossRef] [PubMed]
99. Wang,X.; Qin,X.; Demirtas,H.; Li,J.; Mao,G.; Huo,Y.; Sun,N.; Liu,L.; Xu,X. Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 2007,369,1876-1882. [CrossRef]
100. Lee,M.; Hong,K.; Chang,S.; Saver,J.L. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis. Stroke 2010,41,1205-1212. [CrossRef] [PubMed]
101. Huo,Y.; Li,J.; Qin,X.; Huang,Y.; Wang,X.; Gottesman,R.F.; Tang,G.; Wang,B.; Chen,D.; He,M.; et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China the CSPPT Randomized Clinical Trial. JAMA 2015,313,1325-1335. [CrossRef] [PubMed]
102. Li,Y.; Huang,T.; Zheng,Y.; Muka,T.; Troup,J.; Hu,F.B. Folic acid supplementation and the risk of cardiovascular diseases: A meta-Analysis of randomized controlled trials. J. Am. Heart Assoc. 2016,5,e003768. [CrossRef] [PubMed]
103. Klerk,M.; Verhoef,P.; Clarke,R.; Blom,H.J.; Kok,F.J.; Schouten,E.G.; MTHFR Studies Collaboration Group. MTHFR 677C ! T polymorphism and risk of coronary heart disease-A meta-analysis. JAMA 2002,288,2023-2031. [CrossRef] [PubMed]
104. Lewis,S.J.; Ebrahim,S.; Smith,G.D. Meta-analysis of MTHFR 677C ! T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventive potential of folate? Br. Med. J. 2005,331,1053A-1056A. [CrossRef] [PubMed]
105. Holmes,M.V.; Newcombe,P.; Hubacek,J.A.; Sofat,R.; Ricketts,S.L.; Cooper,J.; Breteler,M.M.B.; Bautista,L.E.; Sharma,P.; Whittaker,J.C.; et al. Effect modification by population dietary folate on the association between MTHFR genotype,homocysteine,and stroke risk: A meta-analysis of genetic studies and randomised trials. Lancet 2011,378,584-594. [CrossRef]
106. Niu,W.-Q.; You,Y.-G.; Qi,Y. Strong association of methylenetetrahydrofolate reductase gene C677T polymorphism with hypertension and hypertension-in-pregnancy in Chinese: A meta-analysis. J. Hum. Hypertens. 2012,26,259-267. [CrossRef] [PubMed]
107. Yang,K.; Jia,J.; Mao,L.; Men,C.; Tang,K.; Li,Y.; Ding,H.; Zhang,Y. Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: A meta-analysis of 10,415 subjects. Biomed. Rep. 2014,2,699-708. [CrossRef] [PubMed]
108. Horigan,G.; McNulty,H.; Ward,M.; Strain,J.J.; Purvis,J.; Scott,J.M. Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C ! T polymorphism in MTHFR. J. Hypertens. 2010,28,478-486. [CrossRef] [PubMed]
109. Wilson,C.P.;Ward,M.; McNulty,H.; Strain,J.J.; Trouton,T.G.; Horigan,G.; Purvis,J.; Scott,J.M. Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: A 4-y follow-up. Am. J. Clin. Nutr. 2012,95,766-772. [CrossRef] [PubMed]
110. Wilson,C.P.; McNulty,H.; Ward,M.; Strain,J.J.; Trouton,T.G.; Hoeft,B.A.; Weber,P.; Roos,F.F.; Horigan,G.; McAnena,L.; et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: Findings of a targeted randomized trial. Hypertension 2013,61,1302-1308. [CrossRef] [PubMed]
111. Gjesdal,C.G.; Vollset,S.E.; Ueland,P.M.; Refsum,H.; Drevon,C.A.; Gjessing,H.K.; Tell,G.S. Plasma total homocysteine level and bone mineral density: The hordaland homocysteine study. Arch. Intern. Med. 2006,166,88-94. [CrossRef] [PubMed]
112. Morris,M.S.; Jacques,P.F.; Selhub,J. Relation between homocysteine and B-vitamin status indicators and bone mineral density in older Americans. Bone 2005,37,234-242. [CrossRef] [PubMed]
113. McLean,R.R.; Jacques,P.F.; Selhub,J.; Tucker,K.L.; Samelson,E.J.; Broe,K.E.; Hannan,M.T.; Cupples,L.A.; Kiel,D.P. Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med. 2004,350,2042-2049. [CrossRef] [PubMed]
114. Yang,J.; Hu,X.; Zhang,Q.; Cao,H.;Wang,J.; Liu,B. Homocysteine level and risk of fracture: A meta-analysis and systematic review. Bone 2012,51,376-382. [CrossRef] [PubMed]
115. Van Wijngaarden,J.P.; Doets,E.L.; Szczecinska,A.; Souverein,O.W.; Duffy,M.E.; Dullemeijer,C.; Cavelaars,A.E.J.M.; Pietruszka,B.; Van’t Veer,P.; Brzozowska,A.; et al. Vitamin B12,folate,homocysteine,and bone health in adults and elderly people: A systematic review with meta-analyses. J. Nutr. Metab. 2013,2013,486186. [CrossRef] [PubMed]
116. Cagnacci,A.; Baldassari,F.; Rivolta,G.; Arangino,S.; Volpe,A. Relation of homocysteine,folate,and vitamin B-12 to bone mineral density of postmenopausal women. Bone 2003,33,956-959. [CrossRef] [PubMed]
117. Tucker,K.L.; Hannan,M.T.; Qiao,N.; Jacques,P.F.; Selhub,J.; Cupples,L.A.; Kiel,D.P. Low plasma vitamin B12 is associated with lower BMD: The Framingham Osteoporosis Study. J. Bone Miner. Res. 2005,20,152-158. [CrossRef] [PubMed]
118. Gjesdal,C.G.; Vollset,S.E.; Ueland,P.M.; Refsum,H.; Meyer,H.E.; Tell,G.S. Plasma homocysteine,folate,and vitamin B 12 and the risk of hip fracture: The hordaland homocysteine study. J. Bone Miner. Res. 2007,22,747-756. [CrossRef] [PubMed]
119. Yazdanpanah,N.; Zillikens,M.C.; Rivadeneira,F.; De Jong,R.; Lindemans,J.; Uitterlinden,A.G.; Pols,H.A.P.; Van Meurs,J.B.J. Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: The Rotterdam Study. Bone 2007,41,987-994. [CrossRef] [PubMed]
120. Dhonukshe-Rutten,R.A.M.; De Vries,J.H.M.; De Bree,A.; Van Der Put,N.; Van Staveren,W.A.; De Groot,L.C.P.G.M. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur. J. Clin. Nutr. 2009,63,18-30. [CrossRef] [PubMed]
121. Dai,Z.; Wang,R.; Ang,L.W.; Yuan,J.-M.; Koh,W.-P. Dietary B vitamin intake and risk of hip fracture: The Singapore Chinese Health Study. Osteoporos. Int. 2013,24,2049-2059. [CrossRef] [PubMed]
122. McLean,R.R.; Jacques,P.F.; Selhub,J.; Fredman,L.; Tucker,K.L.; Samelson,E.J.; Kiel,D.P.; Cupples,L.A.; Hannan,M.T. Plasma B vitamins,homocysteine,and their relation with bone loss and hip fracture in elderly men and women. J. Clin. Endocrinol. Metab. 2008,93,2206-2212. [CrossRef] [PubMed]
123. Rumbak,I.; Zizic,V.; Sokolic,L.; Cvijetic,S.; Kajfez,R.; Baric,I.C. Bone mineral density is not associated with homocysteine level,folate and vitamin B-12 status. Arch. Gynecol. Obstet. 2012,285,991-1000. [CrossRef] [PubMed]
124. Zhu,K.; Beilby,J.; Dick,I.M.; Devine,A.; Soos,M.; Prince,R.L. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos. Int. 2009,20,1183-1191. [CrossRef] [PubMed]
125. Sato,Y.; Honda,Y.; Iwamoto,J.; Kanoko,T.; Satoh,K. Effect of folate and mecobalamin on hip fractures in patients with stroke: A randomized controlled trial. JAMA 2005,293,1082-1088. [CrossRef] [PubMed]
126. Sawka,A.M.; Ray,J.G.; Yi,Q.; Josse,R.G.; Lonn,E. Randomized clinical trial of homocysteine level-lowering therapy and fractures. Arch. Intern. Med. 2007,167,2136-2139. [CrossRef] [PubMed]
127. Gommans,J.; Yi,Q.; Eikelboom,J.W.; Hankey,G.J.; Chen,C.; Rodgers,H.; VITATOPS Trial Study Group. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: Substudy of VITATOPS,a randomised placebo-controlled trial. BMC Geriatr. 2013,13,88. [CrossRef] [PubMed]
128. Enneman,A.W.; Swart,K.M.A.; VanWijngaarden,J.P.; Van Dijk,S.C.; Ham,A.C.; Brouwer-Brolsma,E.M.; Van Der Zwaluw,N.L.; Dhonukshe-Rutten,R.A.M.; van der Cammen,T.J.M.; De Groot,L.C.P.G.M.; et al. Effect of vitamin b12 and folic acid supplementation on bone mineral density and quantitative ultrasound parameters in older people with an elevated plasma homocysteine level: B-PROOF,a randomized controlled trial. Calcif. Tissue Int. 2015,96,401-409. [CrossRef] [PubMed]
129. VanWijngaarden,J.P.; Swart,K.M.A.; Enneman,A.W.; Dhonukshe-Rutten,R.A.M.; Van Dijk,S.C.; Ham,A.C.; Brouwer-Brolsma,E.M.; Van der Zwaluw,N.L.; Sohl,E.; Van Meurs,J.B.J.; et al. Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF,a randomized controlled trial. Am. J. Clin. Nutr. 2014,100,1578-1586. [CrossRef] [PubMed]
130. Wolffe,A.P.; Matzke,M.A. Epigenetics: Regulation through repression. Science 1999,286,481-486. [CrossRef] [PubMed]
131. Robertson,K.D.; Wolffe,A.P. DNA methylation in health and disease. Nat. Rev. Genet. 2000,1,11-19. [CrossRef] [PubMed]
132. Kass,S.U.; Pruss,D.; Wolffe,A.P. How does DNA methylation repress transcription? Trends Genet. 1997,13,444-449. [CrossRef]
133. Bird,A.P.; Wolffe,A.P. Methylation-induced repression-Belts,braces,and chromatin. Cell 1999,99,451-454. [CrossRef]
134. Jones,P.A.; Takai,D. The role of DNA methylation in mammalian epigenetics. Science 2001,293,1068-1070. [CrossRef] [PubMed]
135. Abrahamsen,B.; Madsen,J.S.; Tofteng,C.L.; Stilgren,L.; Bladbjerg,E.M.; Kristensen,S.R.; Brixen,K.; Mosekilde,L. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: Longitudinal data from the Danish osteoporosis prevention study. J. Bone Miner. Res. 2003,18,723-729. [CrossRef] [PubMed]
136. Miyao,M.; Morita,H.; Hosoi,T.; Kurihara,H.; Inoue,S.; Hoshino,S.; Shiraki,M.; Yazaki,Y.; Ouchi,Y. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue Int. 2000,66,190-194. [CrossRef] [PubMed]
137. Hong,X.; Hsu,Y.; Terwedow,H.; Tang,G.; Liu,X.; Jiang,S.; Xu,X.; Xu,X. Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone 2007,40,737-742. [CrossRef] [PubMed]
138. Wang,H.; Liu,C. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: An updated meta-analysis. Osteoporos. Int. 2012,23,2625-2634. [CrossRef] [PubMed]
139. Macdonald,H.M.;McGuigan,F.E.; Fraser,W.D.; New,S.A.; Ralston,S.H.; Reid,D.M. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone 2004,35,957-964. [CrossRef] [PubMed]
140. McLean,R.R.; Karasik,D.; Selhub,J.; Tucker,K.L.; Ordovas,J.M.; Russo,G.T.; Cupples,L.A.; Jacques,P.F.; Kiel,D.P. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J. Bone Miner. Res. 2004,19,410-418. [CrossRef] [PubMed]
141. Abrahamsen,B.; Madsen,J.S.; Tofteng,C.L.; Stilgren,L.; Bladbjerg,E.M.; Kristensen,S.R.; Brixen,K.; Mosekilde,L. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone 2005,36,577-583. [CrossRef] [PubMed]
142. Yazdanpanah,N.; Uitterlinden,A.G.; Zillikens,M.C.; Jhamai,M.; Rivadeneira,F.; Hofman,A.; De Jonge,R.; Lindemans,J.; Pols,H.A.; Van Meurs,J.B. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J. Bone Miner. Res. 2008,23,86-94. [CrossRef] [PubMed]
143. Hedden,T.; Gabrieli,J. Insights into the ageing mind: A view from cognitive neuroscience. Nat. Rev. Neurosci. 2004,5,87-96. [CrossRef] [PubMed]
144. Park,D.C.; Reuter-Lorenz,P. The Adaptive Brain: Aging and Neurocognitive Scaffolding. Annu. Rev. Psychol. 2009,60,173-196. [CrossRef] [PubMed]
145. Busse,A.; Bischkopf,J.; Riedel-Heller,S.G.; Angermeyer,M.C. Mild cognitive impairment: Prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br. J. Psychiatry 2003,182,449-454. [CrossRef] [PubMed]
146. Gauthier,S.; Reisberg,B.; Zaudig,M.; Petersen,R.C.; Ritchie,K.; Broich,K.; Belleville,S.; Brodaty,H.; Bennett,D.; Chertkow,H.; et al. Mild cognitive impairment. Lancet 2006,367,1262-1270. [CrossRef]
147. Esiri,M.; Matthews,F.; Brayne,C.; Ince,P.; Matthews,F.; Xuereb,J.; Broome,J.; McKenzie,J.; Rossi,M.; McKeith,I.; et al. Pathological correlates of late-onset dementia in a multicentre,community-based population in England and Wales. Lancet 2001,357,169-175.
148. Stevens,T.; Livingston,G.; Kitchen,G.; Manela,M.; Walker,Z.; Katona,C. Islington study of dementia subtypes in the community. Br. J. Psychiatry 2002,180,270-276. [CrossRef] [PubMed]
149. Gorelick,P.B.; Scuteri,A.; Black,S.E.; DeCarli,C.; Greenberg,S.M.; Iadecola,C.; Launer,L.J.; Laurent,S.; Lopez,O.L.; Nyenhuis,D.; et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011,42,2672-2713. [CrossRef] [PubMed]
150. Van der Flier,W.; Scheltens,P. Epidemiology and risk factors of dementia. J. Neurol. Neurosurg. Psychiatry 2005,76,V2-V7. [CrossRef] [PubMed]
151. Barber,R.; Panikkar,A.; McKeith,I. Dementia with Lewy bodies: Diagnosis and management. Int. J. Geriatr. Psychiatry 2001,16,S12-S18. [CrossRef]
152. Querfurth,H.W.; LaFerla,F.M. Alzheimer’s Disease. N. Engl. J. Med. 2010,362,329-344. [CrossRef] [PubMed]
153. O’Brien,J.; Paling,S.; Barber,R.; Williams,E.; Ballard,C.; McKeith,I.; Gholkar,A.; Crum,W.; Rossor,M.; Fox,N. Progressive brain atrophy on serial MRI in dementia with Lewy bodies,AD,and vascular dementia. Neurology 2001,56,1386-1388. [CrossRef] [PubMed]
154. DeWilde,M.C.; Kamphuis,P.J.G.H.; Sijben,J.W.C.; Scheltens,P. Utility of imaging for nutritional intervention studies in Alzheimer’s disease. Eur. J. Pharmacol. 2011,668,S59-S69. [CrossRef] [PubMed]
155. Miller,J.W.; Green,R.; Mungas,D.M.; Reed,B.R.; Jagust,W.J. Homocysteine,vitamin B6,and vascular disease in AD patients. Neurology 2002,58,1471-1475. [CrossRef] [PubMed]
156. Smith,A.D. The worldwide challenge of the dementias: A role for B vitamins and homocysteine? Food Nutr. Bull. 2008,29,S143-S172. [CrossRef] [PubMed]
157. Oulhaj,A.; Refsum,H.; Beaumont,H.; Williams,J.; King,E.; Jacoby,R.; Smith,A.D. Homocysteine as a predictor of cognitive decline in Alzheimer’s disease. Int. J. Geriatr. Psychiatry 2010,25,82-90. [CrossRef] [PubMed]
158. Nie,T.; Lu,T.; Xie,L.; Huang,P.; Lu,Y.; Jiang,M. Hyperhomocysteinemia and risk of cognitive decline: A meta-analysis of prospective cohort studies. Eur. Neurol. 2014,72,241-248. [PubMed]
159. Beydoun,M.A.; Beydoun,H.A.; Gamaldo,A.A.; Teel,A.; Zonderman,A.B.; Wang,Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: Systematic review and meta-analysis. BMC Public Health 2014,14,643. [CrossRef] [PubMed]
160. Horvat,P.; Gardiner,J.; Kubinova,R.; Pajak,A.; Tamosiunas,A.; Schoettker,B.; Pikhart,H.; Peasey,A.; Jansen,E.; Bobak,M. Serum folate,vitamin B-12 and cognitive function in middle and older age: The HAPIEE study. Exp. Gerontol. 2016,76,33-38. [CrossRef] [PubMed]
161. De Lau,L.M.L.; Refsum,H.; Smith,A.D.; Johnston,C.; Breteler,M.M.B. Plasma folate concentration and cognitive performance: Rotterdam scan study. Am. J. Clin. Nutr. 2007,86,728-734. [PubMed]
162. Hooshmand,B.; Solomon,A.; Kareholt,I.; Rusanen,M.; Hanninen,T.; Leiviska,J.;Winblad,B.; Laatikainen,T.; Soininen,H.; Kivipelto,M. Associations between serum homocysteine,holotranscobalamin,folate and cognition in the elderly: A longitudinal study. J. Intern. Med. 2012,271,204-212. [CrossRef] [PubMed]
163. Brown,B.; Huang,M.H.; Karlamangla,A.; Seeman,T.; Kado,D. Do the effects of APOE-epsilon4 on cognitive function and decline depend upon vitamin status? MacArthur Studies of Successful Aging. J. Nutr. Health Aging 2011,15,196-201. [CrossRef] [PubMed]
164. Kim,J.; Stewart,R.; Kim,S.; Shin,I.; Yang,S.; Shin,H.; Yoon,J. Changes in folate,vitamin B12 and homocysteine associated with incident dementia. J. Neurol. Neurosurg. Psychiatry 2008,79,864-868. [CrossRef] [PubMed]
165. Erickson,K.I.; Suever,B.L.; Prakash,R.S.; Colcombe,S.J.; McAuley,E.; Kramer,A.F. Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: A voxel-based morphometry study. Brain Res. 2008,1199,20-26. [CrossRef] [PubMed]
166. Moorthy,D.; Peter,I.; Scott,T.M.; Parnell,L.D.; Lai,C.; Crott,J.W.; Ordovas,J.M.; Selhub,J.; Griffith,J.; Rosenberg,I.H.; et al. Status of vitamins B-12 and B-6 but not of folate,homocysteine,and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults. J. Nutr. 2012,142,1554-1560. [CrossRef] [PubMed]
167. Mooijaart,S.P.; Gussekloo,J.; Frolich,M.; Jolles,J.; Stott,D.J.; Westendorp,R.G.J.; De Craen,A.J.M. Homocysteine,vitamin B-12,and folic acid and the risk of cognitive decline in old age: The Leiden 85-Plus study. Am. J. Clin. Nutr. 2005,82,866-871. [PubMed]
168. Kang,J.H.; Irizarry,M.C.; Grodstein,F. Prospective study of plasma folate,vitamin B12,and cognitive function and decline. Epidemiology 2006,17,650-657. [CrossRef] [PubMed]
169. Clarke,R.; Birks,J.; Nexo,E.; Ueland,P.M.; Schneede,J.; Scott,J.; Molloy,A.; Evans,J.G. Low vitamin B-12 status and risk of cognitive decline in older adults. Am. J. Clin. Nutr. 2007,86,1384-1391. [PubMed]
170. Haan,M.N.; Miller,J.W.; Aiello,A.E.; Whitmer,R.A.; Jagust,W.J.; Mungas,D.M.; Allen,L.H.; Green,R. Homocysteine,B vitamins,and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 2007,85,511-517. [PubMed]
171. Lildballe,D.L.; Fedosov,S.; Sherliker,P.; Hin,H.; Clarke,R.; Nexo,E. Association of cognitive impairment with combinations of vitamin B12-related parameters. Clin. Chem. 2011,57,1436-1443. [CrossRef] [PubMed]
172. Tangney,C.C.; Tang,Y.; Evans,D.A.; Morris,M.C. Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline. Neurology 2009,72,361-367. [CrossRef] [PubMed]
173. Morris,M.S.; Selhub,J.; Jacques,P.F. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the Framingham heart study. J. Am. Geriatr. Soc. 2012,60,1457-1464. [CrossRef] [PubMed]
174. O’Leary,F.; Allman-Farinelli,M.; Samman,S. Vitamin B12 status,cognitive decline and dementia: A systematic review of prospective cohort studies. Br. J. Nutr. 2012,108,1948-1961. [CrossRef] [PubMed]
175. Kado,D.M.; Karlamangla,A.S.; Huang,M.; Troen,A.; Rowe,J.W.; Selhub,J.; Seeman,T.E. Homocysteine versus the vitamins folate,B6,and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am. J. Med. 2005,118,161-167. [CrossRef] [PubMed]
176. Riggs,K.M.; Spiro,A.; Tucker,K.; Rush,D. Relations of vitamin B-12,vitamin B-6,folate,and homocysteine to cognitive performance in the normative aging study. Am. J. Clin. Nutr. 1996,63,306-314. [PubMed]
177. Tucker,K.L.; Qiao,N.; Scott,T.; Rosenberg,I.; Spiro,A. High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans affairs normative aging study. Am. J. Clin. Nutr. 2005,82,627-635. [PubMed]
178. Corrada,M.M.; Kawas,C.H.; Hallfrisch,J.; Muller,D.; Brookmeyer,R. Reduced risk of Alzheimer’s disease with high folate intake: The Baltimore Longitudinal Study of Aging. Alzheimer’s Dement. J. Alzheimer’s Assoc. 2005,1,11-18. [CrossRef] [PubMed]
179. Xiu,L.; Lee,M.; Wahlqvist,M.L.; Chen,R.C.; Huang,Y.; Chen,K.; Li,D. Low and high homocysteine are associated with mortality independent of B group vitamins but interactive with cognitive status in a free-living elderly cohort. Nutr. Res. 2012,32,928-939. [CrossRef] [PubMed]
180. Wald,D.S.; Kasturiratne,A.; Simmonds,M. Effect of folic acid,with or without other B vitamins,on cognitive decline: Meta-analysis of randomized trials. Am. J. Med. 2010,123,522-527. [CrossRef] [PubMed]
181. Clarke,R.; Bennett,D.; Parish,S.; Lewington,S.; Skeaff,M.; Eussen,S.J.P.M.; Lewerin,C.; Stott,D.J.; Armitage,J.; Hankey,G.J.; et al. Effects of homocysteine lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials with cognitive data on 22,000 individuals. Am. J. Clin. Nutr. 2014,100,657-666. [CrossRef] [PubMed]
182. McCaddon,A.; Miller,J.W. Assessing the association between homocysteine and cognition: Reflections on Bradford Hill,meta-analyses,and causality. Nutr. Rev. 2015,73,723-735. [CrossRef] [PubMed]
183. Smith,D.; de Jager,C.; Refsum,H.; Rosenberg,I.H. B-vitamin trials meta-analysis: Less than meets the eye. Am. J. Clin. Nutr. 2015,101,415-416. [CrossRef] [PubMed]
184. Garrard,P.; Jacoby,R. Homocysteine lowering,B vitamins,and cognitive aging. Am. J. Clin. Nutr. 2015,101,414-415. [CrossRef] [PubMed]
185. Van der Zwaluw,N.L.; Dhonukshe-Rutten,R.A.M.; Van Wijngaarden,J.P.; Brouwer-Brolsma,E.M.; Van De Rest,O.; In’t Veld,P.H.; Enneman,A.W.; Van Dijk,S.C.; Ham,A.C.; Swart,K.M.A.; et al. Results of 2-year vitamin B treatment on cognitive performance: Secondary data from an RCT. Neurology 2014,83,2158-2166. [CrossRef] [PubMed]
186. Durga,J.; Van Boxtel,M.P.J.; Schouten,E.G.; Kok,F.J.; Jolles,J.; Katan,M.B.; Verhoef,P. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A randomised,double blind,controlled trial. Lancet 2007,369,208-216. [CrossRef]
187. Walker,J.G.; Batterham,P.J.; Mackinnon,A.J.; Jorm,A.F.; Hickie,I.; Fenech,M.; Kljakovic,M.; Crisp,D.; Christensen,H. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms-The beyond ageing project: A randomized controlled trial. Am. J. Clin. Nutr. 2012,95,194-203. [CrossRef] [PubMed]
188. Douaud,G.; Refsum,H.; de Jager,C.A.; Jacoby,R.; Nichols,T.E.; Smith,S.M.; Smith,A.D. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc. Natl. Acad. Sci. USA 2013,110,9523-9528. [CrossRef] [PubMed]
189. Kwok,T.; Lee,J.; Law,C.B.; Pan,P.C.; Yung,C.Y.; Choi,K.C.; Lam,L.C. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people. Clin. Nutr. 2011,30,297-302. [CrossRef] [PubMed]
190. Kang,J.H.; Cook,N.; Manson,J.; Buring,J.E.; Albert,C.M.; Grodstein,F. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am. J. Clin. Nutr. 2008,88,1602-1610. [CrossRef] [PubMed]
191. McMahon,J.A.; Green,T.J.; Skeaff,C.M.; Knight,R.G.; Mann,J.I.; Williams,S.M. A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med. 2006,354,2764-2772. [CrossRef] [PubMed]
192. Balk,E.M.; Raman,G.; Tatsioni,A.; Chung,M.; Lau,J.; Rosenberg,I.H. Vitamin B-6,B-12,and folic acid supplementation and cognitive function-A systematic review of randomized trials. Arch. Intern. Med. 2007,167,21-30. [CrossRef] [PubMed]
193. Brady,C.B.; Gaziano,J.M.; Cxypoliski,R.A.; Guarino,P.D.; Kaufman,J.S.; Warren,S.R.; Hartigan,P.; Goldfarb,D.S.; Jamison,R.L. Homocysteine lowering and cognition in CKD: The Veterans Affairs homocysteine study. Am. J. Kidney Dis. 2009,54,440-449. [CrossRef] [PubMed]
194. Ford,A.H.; Flicker,L.; Alfonso,H.; Thomas,J.; Clarnette,R.; Martins,R.; Almeida,O.P. Vitamins B(12),B(6),and folic acid for cognition in older men. Neurology 2010,75,1540-1547. [CrossRef] [PubMed]
195. De Jager,C.A.; Oulhaj,A.; Jacoby,R.; Refsum,H.; Smith,A.D. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial. Int. J. Geriatr. Psychiatry 2012,27,592-600. [CrossRef] [PubMed]
196. Smith,A.D.; Smith,S.M.; de Jager,C.A.; Whitbread,P.; Johnston,C.; Agacinski,G.; Oulhaj,A.; Bradley,K.M.; Jacoby,R.; Refsum,H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: A randomized controlled trial. PLoS ONE 2010,5,e1224. [CrossRef] [PubMed]
197. Tsai,S.; Hong,C.; Yeh,H.; Liou,Y.; Yang,A.C.; Liu,M.; Hwang,J. Heterozygote advantage of the MTHFR C677T Polymorphism on specific cognitive performance in elderly Chinese males without dementia. Dement. Geriatr. Cogn. Disord. 2011,32,159-163. [CrossRef] [PubMed]
198. Ford,A.H.; Flicker,L.; Hankey,G.J.; Norman,P.; van Bockxmeer,F.M.; Almeida,O.P. Homocysteine,methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: The health in men study. Mol. Psychiatry 2012,17,559-566. [CrossRef] [PubMed]
199. Rai,V. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: A meta-analysis. Mol. Neurobiol. 2016. [CrossRef] [PubMed]
200. Liu,H.; Yang,M.; Li,G.; Qiu,Y.; Zheng,J.; Du,X.; Wang,J.; Liu,R. The MTHFR C677T polymorphism contributes to an increased risk for vascular dementia: A meta-analysis. J. Neurol. Sci. 2010,294,74-80. [CrossRef] [PubMed]
201. Hua,Y.; Zhao,H.; Kong,Y.; Ye,M. Association between the MTHFR Gene and Alzheimer’s Disease: A meta-analysis. Int. J. Neurosci. 2011,121,462-471. [CrossRef] [PubMed]
202. Hooshmand,B.; Mangialasche,F.; Kalpouzos,G.; Solomon,A.; Kareholt,I.; Smith,A.D.; Refsum,H.; Wang,R.; Muhlmann,M.; Ertl-Wagner,B.; et al. Association of vitamin B12,folate,and sulfur amino acids with brain magnetic resonance imaging measures in older adults: A longitudinal population-based study. JAMA Psychiatry 2016,73,606-613. [CrossRef] [PubMed]
203. Kobe,T.;Witte,A.V.; Schnelle,A.; Grittner,U.; Tesky,V.A.; Pantel,J.; Schuchardt,J.P.; Hahn,A.; Bohlken,J.; Rujescu,D.; et al. Vitamin B-12 concentration,memory performance,and hippocampal structure in patients with mild cognitive impairment. Am. J. Clin. Nutr. 2016,103,1045-1054. [CrossRef] [PubMed]
204. Vogiatzoglou,A.; Refsum,H.; Johnston,C.; Smith,S.M.; Bradley,K.M.; De Jager,C.; Budge,M.M.; Smith,A.D. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008,71,826-832. [CrossRef] [PubMed]
205. Tangney,C.C.; Aggarwal,N.T.; Li,H.; Wilson,R.S.; Decarli,C.; Evans,D.A.; Morris,M.C. Vitamin B12,cognition,and brain MRI measures: A cross-sectional examination. Neurology 2011,77,1276-1282. [CrossRef] [PubMed]
206. De Lau,L.M.L.; Smith,A.D.; Refsum,H.; Johnston,C.; Breteler,M.M.B. Plasma vitamin B12 status and cerebral white-matter lesions. J. Neurol. Neurosurg. Psychiatry 2009,80,149-157. [CrossRef] [PubMed]
207. Gallucci,M.; Zanardo,A.; Bendini,M.; Di Paola,F.; Boldrini,P.; Grossi,E. Serum folate,homocysteine,brain atrophy,and auto-CM system: The Treviso Dementia (TREDEM) study. J. Alzheimer’s Dis. 2014,38,581-587.
208. Maestu,F.; Campo,P.; Del Rio,D.; Moratti,S.; Gil-Gregorio,P.; Fernandez,A.; Capilla,A.; Ortiz,T. Increased biomagnetic activity in the ventral pathway in mild cognitive impairment. Clin. Neurophysiol. 2008,119,1320-1327. [CrossRef] [PubMed]
209. Lipton,S.A.; Kim,W.K.; Choi,Y.B.; Kumar,S.; DEmilia,D.M.; Rayudu,P.V.; Arnelle,D.R.; Stamler,J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 1997,94,5923-5928. [CrossRef] [PubMed]
210. Kennedy,B.P.; Bottiglieri,T.; Arning,E.; Ziegler,M.G.; Hansen,L.A.; Masliah,E. Elevated S-adenosylhomocysteine in Alzheimer brain: Influence on methyltransferases and cognitive function. J. Neural Transm. 2004,111,547-567. [CrossRef] [PubMed]
211. Fuso,A.; Seminara,L.; Cavallaro,R.A.; D’Anselmi,F.; Scarpa,S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 2005,28,195-204. [CrossRef] [PubMed]
212. Duthie,S.J.; Narayanan,S.; Brand,G.M.; Pirie,L.; Grant,G. Impact of folate deficiency on DNA stability. J. Nutr. 2002,132,2444S-2449S. [PubMed]
213. Kruman,I.I.; Kumaravel,T.S.; Lohani,A.; Pedersen,W.A.; Cutler,R.G.; Kruman,Y.; Haughey,N.; Lee,J.; Evans,M.; Mattson,M.P. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J. Neurosci. 2002,22,1752-1762. [PubMed]
214. Kruman,I.I.; Culmsee,C.; Chan,S.L.; Mattson,M.P. Folic acid deficiency and homocysteine induce neuronal apoptosis. Soc. Neurosci. 2000,26,93.
215. Selhub,J.; Troen,A.; Rosenberg,I.H. B vitamins and the aging brain. Nutr. Rev. 2010,68,S112-S118. [CrossRef] [PubMed]
216. Bernstein,A.L. Vitamin B6 in clinical neurology. Ann. N. Y. Acad. Sci. 1990,585,250-260. [CrossRef] [PubMed]
217. Tracy,R.P. Emerging relationships of inflammation,cardiovascular disease and chronic diseases of aging. Int. J. Obes. 2003,27,S29-S34. [CrossRef] [PubMed]
218. Dik,M.; Ferrucci,L. Chronic inflammation and common geriatric syndromes: The longitudinal aging study Amsterdam. Gerontologist 2005,45,654-656.
219. Van Oijen,M.; de Jong,F.J.; Witteman,J.C.M.; Hofman,A.; Koudstaal,P.J.; Breteler,M.M.B. Atherosclerosis and risk for dementia. Ann. Neurol. 2007,61,403-410. [CrossRef] [PubMed]
220. Kim,G.; Kim,C.; Park,J.; Lee,K.; Park,C. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996,45,1443-1446. [CrossRef]
221. Masse,P.; Delvin,E.; Hauschka,P.; Donovan,S.; Grynpas,M.; Mahuren,J.; Watkins,B.; Howell,D. Perturbations in factors that modulate osteoblast functions in vitamin B6 deficiency. Can. J. Physiol. Pharmacol. 2000,78,904-911. [CrossRef] [PubMed]
222. Holstein,J.H.; Herrmann,M.; Splett,C.; Herrmann,W.; Garcia,P.; Histing,T.; Klein,M.; Kurz,K.; Siebel,T.; Pohlemann,T.; et al. High bone concentrations of homocysteine are associated with altered bone morphology in humans. Br. J. Nutr. 2011,106,378-382. [CrossRef] [PubMed]
223. Wei,I.L.; Huang,Y.H.; Wang,G.S. Vitamin B-6 deficiency decreases the glucose utilization in cognitive brain structures of rats. J. Nutr. Biochem. 1999,10,525-531. [CrossRef]
224. Fuso,A.; Nicolia,V.; Cavallaro,R.A.; Ricceri,L.; D’Anselmi,F.; Coluccia,P.; Calamandrei,G.; Scarpa,S. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine,depletes brain S-adenosylmethionine,and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 2008,37,731-746. [CrossRef] [PubMed]
225. Wang,B.B.; Jin,F.; Kan,R.; Ji,S.; Zhang,C.F.; Lu,Z.P.; Zheng,C.G.; Yang,Z.;Wang,L. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer’s disease. J. Mol. Neurosci. 2005,27,23-27. [CrossRef]
226. Bi,X.; Zhao,H.; Zhang,Z.; Zhang,J. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer’s disease. Neurobiol. Aging 2009,30,1601-1607. [CrossRef] [PubMed]
227. Global Progress. Available online: http://ffinetwork.org/global_progress/index.php (accessed on 1 September 2016).
228. Williams,J.; Mai,C.T.; Mulinare,J.; Isenburg,J.; Flood,T.J.; Ethen,M.; Frohnert,B.; Kirby,R.S. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification-United States,1995-2011. MMWR Morb. Mortal. Wkly. Rep. 2015,64,1-5. [PubMed]
229. Jacques,P.F.; Selhub,J.; Bostom,A.G.; Wilson,P.W.F.; Rosenberg,I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med. 1999,340,1449-1454. [CrossRef] [PubMed]
230. Morris,M.S.; Jacques,P.F.; Rosenberg,I.H.; Selhub,J. Folate and vitamin B-12 status in relation to anemia,macrocytosis,and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 2007,85,193-200. [PubMed]
231. Bailey,R.L.; Looker,A.C.; Lu,Z.; Fan,R.; Eicher-Miller,H.A.; Fakhouri,T.H.; Gahche,J.J.; Weaver,C.M.; Mills,J.L. B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States. Am. J. Clin. Nutr. 2015,102,687-694. [CrossRef] [PubMed]
232. Hoey,L.; McNulty,H.; Askin,N.; Dunne,A.;Ward,M.; Pentieva,K.; Strain,J.J.; Molloy,A.M.; Flynn,C.A.; Scott,J.M. Effect of a voluntary food fortification policy on folate,related B vitamin status,and homocysteine in healthy adults. Am. J. Clin. Nutr. 2007,86,1405-1413. [PubMed]
233. Hopkins,S.M.; Gibney,M.J.; Nugent,A.P.; McNulty,H.; Molloy,A.M.; Scott,J.M.; Flynn,A.; Strain,J.J.; Ward,M.; Walton,J.; et al. Impact of voluntary fortification and supplement use on dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults. Am. J. Clin. Nutr. 2015,101,1163-1172. [CrossRef] [PubMed]
234. Institute of Medicine Panel. Dietary Reference Intake: Thiamin,Riboflavin,Niacin,Vitamin B6,Vitamin B12,Pantothenic acid,Biotin and Choline; National Academies Press: Washington,DC,USA,2000; pp. 306-356.
235. EFSA NDA Panel. Scientific opinion on dietary reference values for cobalamin (Vitamin B12). EFSA J. 2015,13,4150.
236. Carmel,R.; Green,R.; Rosenblatt,D.S.; Watkins,D. Update on cobalamin,folate,and homocysteine. Hematol. Am. Soc. 2003,1,62-81. [CrossRef]
237. Mills,J.L.; Von Kohorn,I.; Conley,M.R.; Zeller,J.A.; Cox,C.;Williamson,R.E.; Dufour,D.R. Low vitamin B-12 concentrations in patients without anemia: The effect of folic acid fortification of grain. Am. J. Clin. Nutr. 2003,77,1474-1477. [PubMed]
238. Mills,J.L.; Carter,T.C.; Scott,J.M.; Troendle,J.F.; Gibney,E.R.; Shane,B.; Kirke,P.N.; Ueland,P.M.; Brody,L.C.; Molloy,A.M. Do high blood folate concentrations exacerbate metabolic abnormalities in people with low vitamin B-12 status? Am. J. Clin. Nutr. 2011,94,495-500. [CrossRef] [PubMed]
239. Qi,Y.; Hamner,H.; Pfeiffe,C.; Berry,R. The prevalence of low serum vitamin B-12 status in the absence of anemia or macrocytosis did not increase among older U.S. adults after mandatory folic acid fortification. J. Nutr. 2014,144,170-176. [CrossRef] [PubMed]
240. Selhub,J.; Morris,M.S.; Jacques,P.F.; Rosenberg,I.H. Folate-vitamin B-12 interaction in relation to cognitive impairment,anemia,and biochemical indicators of vitamin B-12 deficiency. Am. J. Clin. Nutr. 2009,89,702s-706s. [CrossRef] [PubMed]
241. Moore,E.M.; Ames,D.; Mander,A.G.; Carne,R.P.; Brodaty,H.; Woodward,M.C.; Boundy,K.; Ellis,K.A.; Bush,A.I.; Faux,N.G.; et al. Among vitamin B12 deficient older people,high folate levels are associated with worse cognitive function: Combined data from three cohorts. J. Alzheimer’s Dis. 2014,39,661-668.
242. Clarke,R.; Sherliker,P.; Hin,H.; Molloy,A.M.; Nexo,E.; Ueland,P.M.; Emmens,K.; Scott,J.M.; Evans,J.G. Folate and vitamin B12 status in relation to cognitive impairment and anaemia in the setting of voluntary fortification in the UK. Br. J. Nutr. 2008,100,1054-1059. [CrossRef] [PubMed]
243. Doets,E.L.; Ueland,P.M.; Tell,G.S.; Vollset,S.E.; Nygard,O.K.; Van’t Veer,P.; De Groot,L.C.P.G.M.; Nurk,E.; Refsum,H.; Smith,A.D.; et al. Interactions between plasma concentrations of folate and markers of vitamin B(12) status with cognitive performance in elderly people not exposed to folic acid fortification: The Hordaland Health Study. Br. J. Nutr. 2014,111,1085-1095. [CrossRef] [PubMed]
244. National Toxicology Program. Identifying Research Needs for Safe Use of High Intakes of Folic Acid. 2015. Available online: https://ntp.niehs.nih.gov/ntp/ohat/folicacid/ntpfolicacid_approach_508.pdf (accessed on 1 August 2016).
245. Ebbing,M.; Bonaa,K.H.; Nygard,O.; Arnesen,E.; Ueland,P.M.; Nordrehaug,J.E.; Rasmussen,K.; Njolstad,I.; Refsum,H.; Nilsen,D.W.; et al. Cancer incidence and mortality after treatment with folic acid and vitamin B-12. JAMA 2009,302,2119-2126. [CrossRef] [PubMed]
246. Figueiredo,J.C.; Grau,M.V.; Haile,R.W.; Sandler,R.S.; Summers,R.W.; Bresalier,R.S.; Burke,C.A.; McKeown-Eyssen,G.E.; Baron,J.A. Folic acid and risk of prostate cancer: Results from a randomized clinical trial. J. Natl. Cancer Inst. 2009,101,432-435. [CrossRef] [PubMed]
247. Mason,J.B. Folate consumption and cancer risk: A confirmation and some reassurance,but we’re not out of the woods quite yet. Am. J. Clin. Nutr. 2011,94,965-966. [CrossRef] [PubMed]
248. Report to CMO on Folic Acid and Colorectal Cancer. Available online: https://www.gov.uk/government/ publications/sacn-report-to-cmo-on-folic-acid-and-colorectal-cancer-risk (accessed on 24 August 2016).
249. Troen,A.M.; Mitchell,B.; Sorensen,B.; Wener,M.H.; Johnston,A.; Wood,B.; Selhub,J.; McTiernan,A.; Yasui,Y.; Oral,E.; et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr. 2006,136,189-194. [PubMed]